Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any autosomal dominant non-syndromic intellectual disability in which the cause of the disease is a mutation in the MEF2C gene.
Features include always present findings: Motor delay, Severe intellectual disability, Reduced eye contact, and Delayed ability to sit and others; and very common findings: Inability to walk, Low muscle tone (hypotonia), and Broad forehead. 33 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 9 | Inability to walk, Seizure, Severe intellectual disability |
Arms and legs | 2 | 2-3 toe syndactyly, Clinodactyly of the 5th finger |
Muscles | 1 | Low muscle tone (hypotonia) |
Head and neck | 1 | Thin upper lip vermilion |
Digestive system | 1 | Feeding difficulties |
MEF2C-related disorder is characterized by moderate-to-profound developmental delay with subsequent intellectual disability, lack of speech or speech impairment, limited walking, hypotonia, feeding and gastrointestinal issues, dysmorphic features, seizures, neurobehavioral manifestations including autistic features, cardiac manifestations, and vision issues. Individuals who are able to speak typically only use a few words and are not able to communicate in sentences. Approximately half of individuals are unable to walk independently; however, many are able to walk with some assistance . To date, 142 individuals have been identified with a pathogenic variant in MEF2C including large deletions of all or part of MEF2C .
Source: GeneReviews — "MEF2C-Related Disorder"
MEF2C encodes myocyte enhancer factor 2C (473 aa). Transcription activator which binds specifically to the MEF2 element present in the regulatory regions of many muscle-specific genes. Highest expression in Brain Frontal Cortex BA9 (61.0 TPM) and Cells EBV-transformed lymphocytes (57.6 TPM).
Neurodevelopmental disorder with hypotonia, stereotypic hand movements, and impaired language is associated with mutations in the MEF2C gene on chromosome 5.
The MEF2C protein participates in Expression of MEF2C in cardiogenesis, MEF2C gene expression is inhibited by MECP2, and GATA4, ISL1:LDB1, TBX20, and NKX2-5 bind the MEF2C gene pathways.
MEF2C is classified as a druggable target (Clinically Actionable category) with score 0.0.
At least two individuals with a deletion encompassing only MEF2C exons 1-3 presented with cutaneous vascular malformations, suggesting a possible genotype-phenotype correlation . Individuals with pathogenic variants affecting the proximal region of the MEF2C protein (e.g., within the MADS or MEF2 domains) may be more severely affected than individuals with more distal pathogenic variants . Possible genotype-phenotype correlations associated with MEF2C (e.g., variant type or variant position) require further study. Note: Several reported MEF2C genotype-phenotype correlations compare MEF2C single-nucleotide variants to larger contiguous deletions that encompass additional genes; these are not included in this GeneReview.
Source: GeneReviews — "MEF2C-Related Disorder"
Penetrance is 100%; all individuals who have a MEF2C pathogenic variant have clinical manifestations of the disorder. There have been no reports of unaffected individuals with a pathogenic variant in MEF2C.
Source: GeneReviews — "MEF2C-Related Disorder"
MEF2C-related disorder should be considered in probands with the following clinical and brain MRI findings and family history.
Clinical findings
Source: GeneReviews — "MEF2C-Related Disorder"
The phenotypic features associated with MEF2C-related disorder are not sufficient to diagnose this condition clinically; all disorders with intellectual disability and seizures without other distinctive findings should be considered in the differential diagnosis. See OMIM Phenotypic Series for genes associated with:
• Autosomal dominant intellectual developmental disorders
• Autosomal recessive intellectual developmental disorders
• Nonsyndromic X-linked intellectual developmental disorders
• Syndromic X-linked intellectual developmental disorders
Classic Rett syndrome and Angelman syndrome can be considered in individuals presenting with stereotypic hand movements, intellectual disability, and seizures .
Table 3.
Genes of Interest in the Differential Diagnosis of MEF2C-Related Disorder
Source: GeneReviews — "MEF2C-Related Disorder"
Genetic testing for MEF2C is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for neurodevelopmental disorder with hypotonia, stereotypic hand movements, and impaired language has been reported in the published literature.
No approved treatments are currently available for neurodevelopmental disorder with hypotonia, stereotypic hand movements, and impaired language. The disease remains an area of unmet medical need.
No clinical practice guidelines for MEF2C-related disorder have been published. In the absence of published guidelines, the following recommendations are based on the authors' personal experience managing individuals with this disorder.
To establish the extent of disease and needs in an individual diagnosed with MEF2C-related disorder, the evaluations summarized (if not performed as part of the evaluation that led to diagnosis) are recommended.
Table 4.
MEF2C-Related Disorder: Recommended Evaluations Following Initial Diagnosis
System/Concern | Evaluation | Comment
| Developmental assessment | • To incl motor, adaptive, cognitive, speech-language eval
Eval for early intervention/ special education
| Orthopedics/ physical medicine rehab/ PT OT eval | To incl assessment of:
Gross motor fine motor skills
Mobility, ADL, need for adaptive devices
Need for PT (to improve gross motor skills) /or OT (to improve fine motor skills)
| • Neurologic eval
Cognitive assessment
| • To incl brain MRI
Consider EEG if seizures are a concern.
Gastrointestinal/
| Gastroenterology/ nutrition/ feeding team eval | • To incl eval of aspiration risk nutritional status
Assess for GERD constipation.
Consider eval for gastrostomy tube placement in persons w/dysphagia /or aspiration risk.
Neurobehavioral/
| Neuropsychiatric eval | For persons age 12 mos: screening for ASD, hyperkinesis, agitation, self-injury, breathing issues, sl...
Source: GeneReviews — "MEF2C-Related Disorder"
Search ClinicalTrials.gov in the US and EU Clinical Trials Register in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.
Source: GeneReviews — "MEF2C-Related Disorder"
1 trial found
To monitor existing manifestations, the individual's response to supportive care, and the emergence of new manifestations, the evaluations summarized in are recommended. Table 6. MEF2C-Related Disorder: Recommended Surveillance
System/Concern | Evaluation | Frequency |
|---|---|---|
Development | Monitor developmental progress educational needs. | At each visit Gait abnormalities/ Motor abnormalities |
Neurologic | Assess for new or changing manifestations such as seizures, changes in tone, movement disorders. | At each visit or per treating neurologist |
Neurobehavioral/Psychiatric | Behavioral assessment for ASD, hyperkinesis, agitation, self-injury, breathing issues, sleep issues, high pain tolerance | Annually |
Cardiovascular | Assessment by cardiologist | Per cardiologist |
Ophthalmologic | Ophthalmology eval for strabismus refractive errors | Per ophthalmologist Recurrent infections |
Family/Community | Assess family need for social work support (e.g., palliative/respite care, home nursing, other local resources), care coordination, or follow-up genetic counseling if new questions arise (e.g., family planning). | At each visit ASD = autism spectrum disorder; GERD = gastroesophageal reflux disease; OT = occupational therapy; PT = physical therapy |
Source: GeneReviews — "MEF2C-Related Disorder"
Phenotype severity distribution: 6 always present features, 3 very common features, 10 common features.
1 clinical trial registered, 1 recruiting. Interventions under study include other interventions. Research is primarily sponsored by academic and government institutions.
4 publications have been identified in PubMed for neurodevelopmental disorder with hypotonia, stereotypic hand movements, and impaired language. Kisho has analyzed 3 by research type. Research spans Basic Science / Preclinical (67%) and Diagnostic / Biomarker (33%).
Silva A (2026). [PMID: 41291199](https://pubmed.ncbi.nlm.nih.gov/41291199/). *Eur J Hum Genet*. [Diagnostic / Biomarker]
Yousefian-Jazi A (2025). [PMID: 39920775](https://pubmed.ncbi.nlm.nih.gov/39920775/). *Mol Neurodegener*. [Basic Science / Preclinical]
Yousefian-Jazi A (2024). [PMID: 39071309](https://pubmed.ncbi.nlm.nih.gov/39071309/). *bioRxiv*. [Basic Science / Preclinical]
Data assembled from 8 of 12 sources · Last updated Oct 3, 2026, 7:08 AM UTC
Online Mendelian Inheritance in Man
European rare disease database